‘Dolly’ cloning firm shrug off investment fears

The Scottish firm involved in the cloning of Dolly the sheep was tonight ‘‘fairly confident’’ it would avoid a cash crisis because of a lack of investment.

PPL Therapeutics in Midlothian is currently looking at alternative sources of funding after failing to raise £45 million for further research and development over the next four years.